Strengthening GeoVax’s Team Advancing Gedeptin® Clinical Program ATLANTA, GA, Jan. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced the appointment of J.

加强GeoVax的团队推进Gedeptin®临床计划，佐治亚州亚特兰大，2024年1月8日（环球新闻网）——通过NewMediaWire–GeoVax Labs，Inc.（纳斯达克：GOVX），一家开发针对癌症和传染病的免疫疗法和疫苗的生物技术公司，今天宣布任命J。

Marc Pipas, M.D., to serve as the Company’s Executive Medical Director, Oncology.  Kelly McKee, M.D., MPH, GeoVax Chief Medical Officer, commented, “Dr. Pipas’ addition to our team represents an important step forward in the strengthening of GeoVax’s organizational and operational resources to support advancement of our principal oncology asset, Gedeptin®, through clinical development and regulatory approval.  He is also well-positioned to guide the clinical development of GeoVax’s broader immune-oncology portfolio.

医学博士马克·皮帕斯（MarcPipas）担任该公司肿瘤学执行医学主任。GeoVax首席医疗官、医学博士、公共卫生硕士凯利·麦基评论道，“Pipas博士加入我们的团队意味着在加强GeoVax的组织和运营资源方面迈出了重要的一步，以支持通过临床开发和监管批准推进我们的主要肿瘤学资产Gedeptin®。他还可以很好地指导GeoVax更广泛的免疫肿瘤学组合的临床开发。

We are excited to leverage the wealth of knowledge, expertise, and insights he will provide relative to the clinical developments in support of our oncology programs.” “I am pleased to be joining the GeoVax team,” said Dr. Pipas. “Oncologic research and development is my passion and I look forward to engaging with our clinical researchers, regulatory authorities, and the medical community at large, to advance GeoVax’s mission.” Dr.

我们很高兴能够利用他将提供的有关临床发展的丰富知识，专业知识和见解来支持我们的肿瘤学计划。”“我很高兴加入GeoVax团队，”皮帕斯博士说。“肿瘤研究和开发是我的热情所在，我期待着与我们的临床研究人员、监管机构和整个医学界合作，以推进GeoVax的使命。”。

Pipas has extensive clinical, research, and leadership expertise in oncology, built on a long and successful academic career at Dartmouth-Hitchcock Medical Center/Norris Cotton Cancer Center, an NCI Comprehensive Cancer Center.  During his academic career, Dr Pipas led the GI Clinical Oncology Group for >10 years, served as Hematology/Oncology Fellowship Director, was Medical Director for the Office of Clinical Research in the Cancer Center, and served for more than a decade as a member of Human Subject Protection and Data Mon.

Pipas在肿瘤学方面拥有广泛的临床，研究和领导专业知识，建立在达特茅斯希区柯克医学中心/诺里斯棉花癌症中心（NCI综合癌症中心）长期成功的学术生涯之上。在他的学术生涯中，Pipas博士领导GI临床肿瘤学小组超过10年，担任血液学/肿瘤学奖学金主任，担任癌症中心临床研究办公室的医学主任，并作为人类受试者保护和数据监测的成员服务了十多年。